{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:33:32Z","timestamp":1740123212179,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11095-022-03354-3","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T22:02:46Z","timestamp":1659736966000},"page":"2885-2903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Process Modelling, Scale-Up and Characterization of Acetaminophen Spray Dried Milk Powder as Novel Pediatric Dosage Form"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-5617","authenticated-orcid":false,"given":"Harsh S.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmilasri","family":"Syamala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushbu","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jignasa","family":"Savjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shital","family":"Butani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"3354_CR1","unstructured":"Health UDo, Services H. Guidance for industry: dosage delivery devices for OTC liquid drug products 2009 [Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM188992.pdf."},{"issue":"23","key":"3354_CR2","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1001\/jama.2010.1797","volume":"304","author":"HS Yin","year":"2010","unstructured":"Yin HS, Wolf MS, Dreyer BP, Sanders LM, Parker RM. Evaluation of consistency in dosing directions and measuring devices for pediatric nonprescription liquid medications. Jama. 2010;304(23):2595\u2013602.","journal-title":"Jama"},{"issue":"1","key":"3354_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1517\/17425247.4.1.37","volume":"4","author":"J Breitkreutz","year":"2007","unstructured":"Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Exp Opin Drug Del. 2007;4(1):37\u201345.","journal-title":"Exp Opin Drug Del"},{"key":"3354_CR4","unstructured":"Agency EM. Reflection paper: formulations of choice for the paediatric population. EMEA\/CHMP\/PEG\/194810\/2005. 2006."},{"issue":"2","key":"3354_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1208\/s12249-016-0558-3","volume":"18","author":"DA Van Riet-Nales","year":"2017","unstructured":"Van Riet-Nales DA, Kozarewicz P, Aylward B, de Vries R, Egberts TC, Rademaker CM, et al. Paediatric drug development and formulation design\u2014a European perspective. AAPS PharmSciTech. 2017;18(2):241\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"3354_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejps.2015.02.015","volume":"75","author":"M Slavkova","year":"2015","unstructured":"Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci. 2015;75:2\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"3354_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1208\/s12249-015-0313-1","volume":"16","author":"M Preis","year":"2015","unstructured":"Preis M. Orally disintegrating films and mini-tablets\u2014innovative dosage forms of choice for pediatric use. AAPS PharmSciTech. 2015;16(2):234\u201341.","journal-title":"AAPS PharmSciTech"},{"key":"3354_CR8","first-page":"84","volume":"5","author":"H Shah","year":"2014","unstructured":"Shah H, Parikh D, Butani S. Formulation development & optimisation of milk dissolving tablets as novel paediatric dosage form. Int J Drug Form Res. 2014;5:84\u201396.","journal-title":"Int J Drug Form Res"},{"key":"3354_CR9","unstructured":"Doolaanea A, Bahari A. Advantages of jelly over liquid formulations for pediatrics. J Form Sci Bioavail. 2017;1(1)."},{"issue":"3","key":"3354_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4038\/cmj.v61i3.8340","volume":"61","author":"K Hoppu","year":"2016","unstructured":"Hoppu K. Time to change the paradigm of children's medicines from liquid formulations to flexible solid oral dosage forms. Ceylon Med J. 2016;61(3):93\u20135.","journal-title":"Ceylon Med J"},{"key":"3354_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2013.10.006","volume":"73","author":"HK Batchelor","year":"2014","unstructured":"Batchelor HK, Fotaki N, Klein S. Paediatric oral biopharmaceutics: key considerations and current challenges. Adv Drug Deliv Rev. 2014;73:102\u201326.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3354_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MJT.0b013e3182459c53","volume":"21","author":"K Heard","year":"2014","unstructured":"Heard K, Bui A, Mlynarchek SL, Green JL, Bond GR, Clark RF, et al. Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases. Am J Ther. 2014;21(3):174.","journal-title":"Am J Ther"},{"issue":"1","key":"3354_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00894-011-1040-5","volume":"18","author":"H Hejaz","year":"2012","unstructured":"Hejaz H, Karaman R, Khamis M. Computer-assisted design for paracetamol masking bitter taste prodrugs. J Mol Model. 2012;18(1):103\u201314.","journal-title":"J Mol Model"},{"issue":"16","key":"3354_CR14","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.1021\/ie900248f","volume":"48","author":"SV Dalvi","year":"2009","unstructured":"Dalvi SV, Dave RN. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Ind Eng Chem Res. 2009;48(16):7581\u201393.","journal-title":"Ind Eng Chem Res"},{"issue":"1\u20132","key":"3354_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-5173(02)00261-2","volume":"243","author":"E Reverchon","year":"2002","unstructured":"Reverchon E, De Marco I, Della PG. Rifampicin microparticles production by supercritical antisolvent precipitation. Int J Pharm. 2002;243(1\u20132):83\u201391.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"3354_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ijpharm.2014.05.055","volume":"471","author":"S Belotti","year":"2014","unstructured":"Belotti S, Rossi A, Colombo P, Bettini R, Rekkas D, Politis S, et al. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction. Int J Pharm. 2014;471(1\u20132):507\u201315.","journal-title":"Int J Pharm"},{"key":"3354_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2014.06.059","volume":"192","author":"S Kumar","year":"2014","unstructured":"Kumar S, Shen J, Burgess DJ. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole. J Control Release. 2014;192:95\u2013102.","journal-title":"J Control Release"},{"key":"3354_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijpharm.2019.01.054","volume":"559","author":"BY Gajera","year":"2019","unstructured":"Gajera BY, Shah DA, Dave RH. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology. Int J Pharm. 2019;559:348\u201359.","journal-title":"Int J Pharm"},{"issue":"11","key":"3354_CR19","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1021\/acs.cgd.0c01003","volume":"20","author":"HS Shah","year":"2020","unstructured":"Shah HS, Chaturvedi K, Dave RH, Bates S, Haware RV, Morris KR. New insights on warfarin sodium 2-propanol solvate solid-state changes using a multivariate approach. Cryst Growth Des. 2020;20(11):7328\u201340.","journal-title":"Cryst Growth Des"},{"issue":"10","key":"3354_CR20","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1021\/acs.cgd.8b00534","volume":"18","author":"TV Joshi","year":"2018","unstructured":"Joshi TV, Singaraju AB, Shah HS, Morris KR, Stevens LL, Haware RV. Structure\u2013mechanics and compressibility profile study of flufenamic acid: nicotinamide cocrystal. Cryst Growth Des. 2018;18(10):5853\u201365.","journal-title":"Cryst Growth Des"},{"issue":"1","key":"3354_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1208\/s12249-018-1264-0","volume":"20","author":"HS Shah","year":"2019","unstructured":"Shah HS, Chaturvedi K, Hamad M, Bates S, Hussain A, Morris K. New insights on solid-state changes in the levothyroxine sodium pentahydrate during dehydration and its relationship to chemical instability. AAPS PharmSciTech. 2019;20(1):39.","journal-title":"AAPS PharmSciTech"},{"key":"3354_CR22","unstructured":"Chapter G. <1174> Powder flow. USP-NF 2021. 2021."},{"issue":"4","key":"3354_CR23","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1021\/acs.molpharmaceut.1c00034","volume":"18","author":"HS Shah","year":"2021","unstructured":"Shah HS, Chaturvedi K, Dave RH, Morris KR. Molecular insights into warfarin sodium 2-propanol solvate solid form changes and disproportionation using a low volume two-stage dissolution approach. Mol Pharm. 2021;18(4):1779\u201391.","journal-title":"Mol Pharm"},{"issue":"2","key":"3354_CR24","first-page":"211","volume":"75","author":"GR Lakhwani","year":"2013","unstructured":"Lakhwani GR, Sherikar O, Mehta PJ. Nondestructive and rapid concurrent estimation of paracetamol and nimesulide in their combined dosage form using raman spectroscopic technique. Indian J Pharm Sci. 2013;75(2):211.","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"3354_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/jps.20477","volume":"95","author":"L Kalantzi","year":"2006","unstructured":"Kalantzi L, Reppas C, Dressman J, Amidon G, Junginger H, Midha K, et al. Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol). J Pharm Sci. 2006;95(1):4\u201314.","journal-title":"J Pharm Sci"},{"issue":"6","key":"3354_CR26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.pcl.2011.09.007","volume":"58","author":"A Sylvetsky","year":"2011","unstructured":"Sylvetsky A, Rother KI, Brown R. Artificial sweetener use among children: epidemiology, recommendations, metabolic outcomes, and future directions. Pediatr Clin N Am. 2011;58(6):1467.","journal-title":"Pediatr Clin N Am"},{"issue":"3","key":"3354_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/03639045.2012.758636","volume":"40","author":"DH Choi","year":"2014","unstructured":"Choi DH, Kim NA, Nam TS, Lee S, Jeong SH. Evaluation of taste-masking effects of pharmaceutical sweeteners with an electronic tongue system. Drug Dev Ind Pharm. 2014;40(3):308\u201317.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"3354_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1248\/cpb.c18-00629","volume":"67","author":"H Takano","year":"2019","unstructured":"Takano H, Uchida S, Kashiwagura Y, Tanaka S, Hakamata A, Odagiri K, et al. Preparation of cocoa powder-containing orally disintegrating tablets of rebamipide (rebamipide chocolet) and evaluation of their clinical palatability. Chem Pharm Bull. 2019;67(2):112\u20139.","journal-title":"Chem Pharm Bull"},{"issue":"7","key":"3354_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.arcped.2019.09.008","volume":"26","author":"K Nakama","year":"2019","unstructured":"Nakama K, Dos Santos R, Serpa P, Maciel T, Haas S. Organoleptic excipients used in pediatric antibiotics. Arch Pediatr. 2019;26(7):431\u20136.","journal-title":"Arch Pediatr"},{"issue":"4","key":"3354_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10408398.2010.500231","volume":"52","author":"R Nagpal","year":"2012","unstructured":"Nagpal R, Behare P, Kumar M, Mohania D, Yadav M, Jain S, et al. Milk, milk products, and disease free health: an updated overview. Crit Rev Food Sci Nutr. 2012;52(4):321\u201333.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3354_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cis.2015.05.003","volume":"223","author":"A Sosnik","year":"2015","unstructured":"Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv Colloid Interf Sci. 2015;223:40\u201354.","journal-title":"Adv Colloid Interf Sci"},{"issue":"2","key":"3354_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jfoodeng.2008.10.020","volume":"94","author":"EH-J Kim","year":"2009","unstructured":"Kim EH-J, Chen XD, Pearce D. Surface composition of industrial spray-dried milk powders. 2. Effects of spray drying conditions on the surface composition. J Food Eng. 2009;94(2):169\u201381.","journal-title":"J Food Eng"},{"issue":"3","key":"3354_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-020-2778-1","volume":"37","author":"LM De Mohac","year":"2020","unstructured":"De Mohac LM, Caruana R, Cavallaro G, Giammona G, Licciardi M. Spray-drying, solvent-casting and freeze-drying techniques: a comparative study on their suitability for the enhancement of drug dissolution rates. Pharm Res. 2020;37(3):1\u201311.","journal-title":"Pharm Res"},{"key":"3354_CR34","unstructured":"Chemistry NZIo. Milk Powder 2017 [Available from: https:\/\/nzic.org.nz\/app\/uploads\/2017\/10\/3C.pdf."},{"issue":"3","key":"3354_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3109\/10717544.2014.923066","volume":"23","author":"S Gora","year":"2016","unstructured":"Gora S, Mustafa G, Sahni JK, Ali J, Baboota S. Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study. Drug Deliv. 2016;23(3):930\u201340.","journal-title":"Drug Deliv"},{"key":"3354_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cej.2011.12.044","volume":"181","author":"AA Thorat","year":"2012","unstructured":"Thorat AA, Dalvi SV. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective. Chem Eng J. 2012;181:1\u201334.","journal-title":"Chem Eng J"},{"key":"3354_CR37","unstructured":"Koch R. The 80\/20 principle: the secret of achieving more with less: updated 20th anniversary edition of the productivity and business classic: Hachette UK; 2011."},{"key":"3354_CR38","unstructured":"Zaki HM. Spectroscopy surface analysis of paracetamol and paracetamol and excipient systems: The University of Manchester (United Kingdom); 2011."},{"key":"3354_CR39","unstructured":"Muth N. Recommended Drinks for Young Children Ages 0\u20135: Healthy Living; 2019 [Available from: https:\/\/www.healthychildren.org\/English\/healthy-living\/nutrition\/Pages\/Recommended-Drinks-for-Young-Children-Ages-0-5.aspx."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03354-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03354-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03354-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:19:22Z","timestamp":1667492362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-022-03354-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3354"],"URL":"https:\/\/doi.org\/10.1007\/s11095-022-03354-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interests\/competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests\/Competing Interests"}}]}}